Log in or Sign up
to access My Account functionalities
Pre-treatment testing to identify DPD-deficient patients at increased risk of severe and fatal toxicity
Direct Healthcare Professional Communication regarding
5-Fluorouracil (i.v.), Capecitabine and Tegafur containing products - Pre-treatment testing to identify DPD-deficient patients at increased risk of severe and fatal toxicity